The approval is supported by two randomized, double-blind, placebo-controlled Phase III trials that enrolled a total 1,220 patients with alopecia areata who had at least 50% scalp hair loss
Additional indications Knee osteoarthritis, sleep apnea, MASLD, cardiovascular outcomes, and chronic low back pain would follow based on their respective trial timelines This mirrors how Lilly handled tirzepatide: Mounjaro was approved for diabetes first (May 2022), followed by Zepbound for obesity (November 2023)
Food Interactions and Semaglutide Absorption Injectable semaglutide has no food interactions because it bypasses oral absorption entirely
Drucker suspects, however, that it has to do with semaglutides ability to circulate longer in the body without degrading, possibly combined with an ability to bind to the GLP-1 receptor more strongly than older drugs
Specifications Storage & Handling Lyophilized BPC-157 research material should be stored at -20C, kept away from humidity and UV exposure